Trial NCT02576977

View at ClinicalTrials.gov 
Org. Study IDs: 3475-183
Secondary IDs: 163146 2015-002509-13 KEYNOTE-183 MK-3475-183

Last trial update was posted on 2021-10-08

MeSH Interventions

Dexamethasone Pembrolizumab Pomalidomide

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions


Stopping Reasons

The study was terminated early due to business reasons

Limitations And Caveats

The MK-3475-183 study was stopped/terminated early. Endpoint statistics may be biased due to the incomplete treatment and follow-up of participants after study termination

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID